Expression of peptide receptors in human endocrine tumours of the pancreas

Gut

Volumn 40, Issue 2, 1997, Pages 267-271

  Tang, C ^a   Biemond, I ^a   Lamers, C B H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endocrine tumour; Gut hormone receptor; Pancreas

Indexed keywords

BOMBESIN RECEPTOR; CHOLECYSTOKININ B RECEPTOR; GASTRIN RECEPTOR; HORMONE RECEPTOR; SOMATOSTATIN RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ADULT; ARTICLE; AUTORADIOGRAPHY; CLINICAL ARTICLE; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMAN; HUMAN TISSUE; MALE; PANCREAS TUMOR; PRIORITY JOURNAL; SOMATOSTATINOMA;

EID: 0031043377     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.2.267     Document Type: Article

References (27)

1. Hammond PJ, Polak JM, Bloom SR. Miscellaneous tumours of the pancreas. In: Go VLW, et al, eds, The pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993: 997-1007.
2. Jensen RT, Norton JA. Endocrine neoplasms of the pancreas. In: Go VLW, et al, ed. The pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993: 1912-37.
3. Öberg K. Clinical syndrome, diagnosis and therapy of GI-endocrine tumours and MEN-1. In: Singer MV, et al, eds. Gastrointestinal tract and endocrine system. Dordrecht: Kluwer Academic, 1995: 406-16.
4. Lamberts SWJ, Krenning EP, Reubi J. The role of somatostatin and its analogue in the diagnosis and treatment of tumours. Endocr Rev 1991; 12: 450-82.
5. Chiba T, Yamatani Y, Yamaguchi A, Morishital T, Nakamura A, Kadowaki S, et al. Mechanism for increase of gastrin release by secretin in Zollinger-Ellison syndrome. Gastroenterology 1989; 96: 1439-44.
6. Gower WR, Ellison EC, Knierim TH, Elkhammas EA, O'Dorisio TM, Fabri PJ. Gastrinoma in vitro: morphological and physiological studies of primary cell cultures. Gastroenterology 1990; 98: 936-54.
7. Gower WR, Buzogany JA Jr, Ellison EC, Knierim TH, Fabri PJ. Control and gastrin release from gastrinoma-derived G cells. Surgery 1988; 104: 424-30.
8. Ellison EC, Gower WR, Elkhammas EA, Elkhammas E, Woltering EA, Sparks J, et al. Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995). Am J Med 1986; 81 (suppl): 56-64.
9. Reubi J-C, Häcki WH, Lamberts SWJ. Hormone-producing gastrointestinal tumours contain a high density of somatostatin receptors. J Clin Endocrinol Metab 1987; 65: 1127-34.
10. Jensen RT, Gardner JD. Gastrinoma. In: Go VLW, et al, eds. The pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993: 931-78.
11. Taylor IL, Mannon P. Gastrointestinal hormones. In: Go VLW, et al, eds. The pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993: 24-49.
12. Virgolini I, Yang Q, Li S, Angelberger P, Neuhold N, Niederlo B, et al. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumour cell membrane receptors. Cancer Res 1994; 54: 690-700.
13. Estival A, Mouniélou P, Trocheris V, Scemama JL, Clemente F, Hollande E, et al. Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation. Biochem Biophys Res Commun 1983; 111: 958-63.
14. Svoboda M, De Neef P, Tastenoy M, Christophe J. Molecular characteristics and evidence for internalization of vasoactive-intestinal-peptide (VTP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2 J. Eur J Biochem 1988; 176: 707-13.
15. Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang Q, et al. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumours. N Engl J Med 1994; 331: 1116-21.
16. Douglas BR, Woutersen RA, Jansen JBMJ, de Jong AJL, Rovati LC, Lamers CBHW. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Gastroenterology 1989; 96: 426-9.
17. Tang C, Biemond I, Lamers CBHW. Localization and quantification of cholecystokinin receptors in rat brain with storage phosphor autoradiography. BioTechniques 1995; 18: 886-9.
18. Jansen JBMJ, Lamers CBHW. Low binding of Bolton-Hunter-labelled cholecystokinin-33 to carboxyl-terminal CCK-antibodies. J Immunol Methods 1982; 51: 223-30.
19. Ensinck JW, Laschansky EC, Vogel RE, Simonowitz DA, Roos BA, Francis BH. Circulating prosomatostatin-derived peptides. Differential responses to food ingestion. J Clin Invest 1989; 83: 1580-9.
20. 125I-labelled synthetic porcine secretin for radio-immunoassay. Scand J Clin Lab Invest 1976; 36: 661-8.
21. Schrenck TV, Moran TH, Heinz-Erian P, Gardner JD, Jensen RT. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study. Am J Physiol 1988; 255: G512-21.
22. Leroux P, Quirion R, Pelletier G. Localization and characterization of brain somatostatin receptors as studied with somatostatin-14 and somatostatin-28 receptor autoradiography. Brain Res 1985; 347: 74-84.
23. Munson PJ, Rodbard D. LIGAND: Characterizations of binding systems: a versatile, computerized approach. Anal Biochem 1980; 107: 220-9.
24. Brady CE, Utts SJ, Hyatt JR, Dea J. Secretin provocation: gastrin results in various clinical situation. Am J Gastroenterol 1988; 83: 150-5.
25. Rozengurt E. Bombesin-induction of cell proliferation in 3T3 cells. Ann New York Acad Sci 1988; 547: 277-92.
26. Johnson LR. Effects of gastrointestinal hormones on pancreatic growth. Cancer 1983; 47: 1640-5.
27. Wank SA, Pisegna JR, de Weerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 1992; 89: 8691-5.